{"nctId":"NCT02934698","briefTitle":"An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations","startDateStruct":{"date":"2016-11-01","type":"ACTUAL"},"conditions":["Cystic Fibrosis"],"count":2,"armGroups":[{"label":"Ivacaftor","type":"EXPERIMENTAL","interventionNames":["Drug: Ivacaftor"]}],"interventions":[{"name":"Ivacaftor","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects are \\>18 years of age and able to provide informed consent.\n* Subjects reside in the US and are willing to be treated with ivacaftor.\n* Subjects have the splicing mutation of interest.\n* Subjects are willing and able to perform requirements of the study.\n\nExclusion Criteria:\n\n* There are no relevant exclusion criteria for this n-of-2 study.","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Forced Expiratory Volume","description":"Absolute change in percent predicted in 1 second FEV1 from baseline through week 24","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Sputum Results","description":"Achievement of mycobacterial culture conversion (negative culture)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Sweat Chloride","description":"Testing efficacy through gathering absolute change in sweat chloride from baseline through week 24","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":2},"commonTop":["Sinus congestion","Folliculitis","palpitations"]}}}